Pulike Biological Engineering, Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • 603566
  • 1d-0.74%
  • 1w-5.25%
  • 1m4.92%
  • 1y-35.44%
ATH
  • ATH Price$38.19
  • ATH Date2015-06-05
  • % since ATH-54.17%
  • % to ATH118.21%
ATL
  • ATL Price$10.05
  • ATL Date2015-05-18
  • % from ATL74.10%
  • Last Low Price$10.1388
  • Last Low Date2018-10-18
  • % From Last Low72.60%
IPO
  • IPO Price$22.35
  • % Current ROI USD-21.70%
  • ATH Price$38.19
  • % ROI ATH 37,990.99%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="603566"]

Key Data [addtoany]

Current price $17.5
Sector Healthcare
Industry Biotechnology
Today's High/Low $17.96/$17.36
Volume 949,200.00
Previous Close $17.63
52 Week High/Low $28.3859/$12.89
Market Cap 6,101,072,896.00
P/E Ratio 27.1231
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0.69
Annualized Dividend $0.0369
$17.5
[addtoany]

Pulike Biological Engineering, Inc. engages in the research and development, production, and operation of veterinary biological products and drugs.
It offers vaccines and antibodies for poultry; and poultry and pig medicines, as well as other medicines.
The company is headquartered in Luoyang City, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity